BridgeMD
Compares treatment options for Periodontitis
Official title Modified Widman Flap vs Fibre Retention Osseous Resective Surgery
ClinicalTrials.gov ID: NCT06123000
What this study is testing
- What it's testing
- The treatment of periodontitis should be carried out in an incremental manner, first by achieving adequate patient's oral hygiene practices and risk factor control during the first step of therapy and then, during the second step of therapy, by professional elimination (reduction) of supra and subgingival biofilm and calculus. If the endpoints of therapy (no periodontal pockets \>4 mm with bleeding on probing, BoP, or deep pockets ≥5 mm) have not been achieved, the third step of therapy should be implemented.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years;
- Patients affected by periodontitis;
- No systemic disease or pregnancy;
- No systemic antibiotic therapy in 6 months preceding the enrollment;
- Smoking ≤ 20 cigarettes/day;
You likely can't join if
- Undetectable cemento-enamel junction (CEJ) at experimental teeth;
- Severe furcation involvement (class II and III);
- Abutment for prosthetic rehabilitation;
- Periodontal Pockets associated with infrabony defect \>3 mm;
- Horizontal bone loss higher than 1/3 of the root length at experimental teeth;
- Severe tooth mobility at baseline (class 2 or 3).
See the full eligibility criteria
- Age ≥ 18 years;
- Patients affected by periodontitis;
- No systemic disease or pregnancy;
- No systemic antibiotic therapy in 6 months preceding the enrollment;
- Smoking ≤ 20 cigarettes/day;
- Full-mouth plaque score (FMPS) and full- mouth bleeding score (FMBS) ≤ 15%;
- Residual periodontal pocket ≥5 mm with bleeding on probing at posterior natural teeth;
- Experimental pocket associated with a detectable infrabony defect ≤ 3mm at x-ray;
- No history of periodontal surgery at the experimental site.
- Undetectable cemento-enamel junction (CEJ) at experimental teeth;
- Severe furcation involvement (class II and III);
- Abutment for prosthetic rehabilitation;
- Periodontal Pockets associated with infrabony defect \>3 mm;
- Horizontal bone loss higher than 1/3 of the root length at experimental teeth;
- Severe tooth mobility at baseline (class 2 or 3).
The study team makes the final eligibility decision.
Where it's taking place
- Florence, FI, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Florence, FI, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.